{"pmid":32291633,"title":"Locating and repurposing anesthetic machines as intensive care unit ventilators during the COVID-19 pandemic.","text":["Locating and repurposing anesthetic machines as intensive care unit ventilators during the COVID-19 pandemic.","Can J Anaesth","Orser, Beverley A","Byrick, Robert","Cooper, Richard","Henry, Elihu","Lau, Philip","Rittenberg, Brian","Wiegelmann, Julian","32291633"],"journal":"Can J Anaesth","authors":["Orser, Beverley A","Byrick, Robert","Cooper, Richard","Henry, Elihu","Lau, Philip","Rittenberg, Brian","Wiegelmann, Julian"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32291633","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s12630-020-01657-w","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664266295734960128,"score":8.233237,"similar":[{"pmid":32054124,"pmcid":"PMC7073840","title":"Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations.","text":["Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations.","The outbreak of pneumonia originating in Wuhan, China, has generated 24,500 confirmed cases, including 492 deaths, as of 5 February 2020. The virus (2019-nCoV) has spread elsewhere in China and to 24 countries, including South Korea, Thailand, Japan and USA. Fortunately, there has only been limited human-to-human transmission outside of China. Here, we assess the risk of sustained transmission whenever the coronavirus arrives in other countries. Data describing the times from symptom onset to hospitalisation for 47 patients infected early in the current outbreak are used to generate an estimate for the probability that an imported case is followed by sustained human-to-human transmission. Under the assumptions that the imported case is representative of the patients in China, and that the 2019-nCoV is similarly transmissible to the SARS coronavirus, the probability that an imported case is followed by sustained human-to-human transmission is 0.41 (credible interval [0.27, 0.55]). However, if the mean time from symptom onset to hospitalisation can be halved by intense surveillance, then the probability that an imported case leads to sustained transmission is only 0.012 (credible interval [0, 0.099]). This emphasises the importance of current surveillance efforts in countries around the world, to ensure that the ongoing outbreak will not become a global pandemic.","J Clin Med","Thompson, Robin N","32054124"],"abstract":["The outbreak of pneumonia originating in Wuhan, China, has generated 24,500 confirmed cases, including 492 deaths, as of 5 February 2020. The virus (2019-nCoV) has spread elsewhere in China and to 24 countries, including South Korea, Thailand, Japan and USA. Fortunately, there has only been limited human-to-human transmission outside of China. Here, we assess the risk of sustained transmission whenever the coronavirus arrives in other countries. Data describing the times from symptom onset to hospitalisation for 47 patients infected early in the current outbreak are used to generate an estimate for the probability that an imported case is followed by sustained human-to-human transmission. Under the assumptions that the imported case is representative of the patients in China, and that the 2019-nCoV is similarly transmissible to the SARS coronavirus, the probability that an imported case is followed by sustained human-to-human transmission is 0.41 (credible interval [0.27, 0.55]). However, if the mean time from symptom onset to hospitalisation can be halved by intense surveillance, then the probability that an imported case leads to sustained transmission is only 0.012 (credible interval [0, 0.099]). This emphasises the importance of current surveillance efforts in countries around the world, to ensure that the ongoing outbreak will not become a global pandemic."],"journal":"J Clin Med","authors":["Thompson, Robin N"],"date":"2020-02-15T11:00:00Z","year":2020,"_id":"32054124","week":"20207|Feb 10 - Feb 16","doi":"10.3390/jcm9020498","keywords":["2019-nCoV","SARS","Wuhan","coronavirus","forecasting","infectious disease epidemiology","major outbreak","mathematical modelling"],"source":"PubMed","locations":["South Korea","Wuhan","China","Thailand","USA","Japan"],"countries":["United States","Japan","Thailand","Korea, Republic of","China"],"countries_codes":["USA|United States","JPN|Japan","THA|Thailand","KOR|Korea, Republic of","CHN|China"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1663352134663405570,"score":56.18044},{"pmid":32151274,"pmcid":"PMC7063757","title":"Preparing for COVID-19: early experience from an intensive care unit in Singapore.","text":["Preparing for COVID-19: early experience from an intensive care unit in Singapore.","Crit Care","Liew, Mei Fong","Siow, Wen Ting","MacLaren, Graeme","See, Kay Choong","32151274"],"journal":"Crit Care","authors":["Liew, Mei Fong","Siow, Wen Ting","MacLaren, Graeme","See, Kay Choong"],"date":"2020-03-11T11:00:00Z","year":2020,"_id":"32151274","week":"202011|Mar 09 - Mar 15","doi":"10.1186/s13054-020-2814-x","link_comment_for":"32070391","source":"PubMed","locations":["Singapore"],"countries":["Singapore"],"countries_codes":["SGP|Singapore"],"topics":["Prevention"],"weight":1,"_version_":1663352134116048899,"score":55.513447},{"pmid":32235155,"title":"Setup of a Dedicated Coronavirus Intensive Care Unit: Logistical Aspects.","text":["Setup of a Dedicated Coronavirus Intensive Care Unit: Logistical Aspects.","Anesthesiology","Mojoli, Francesco","Mongodi, Silvia","Grugnetti, Giuseppina","Muzzi, Alba","Baldanti, Fausto","Bruno, Raffaele","Triarico, Antonio","Antonio Iotti, Giorgio","32235155"],"journal":"Anesthesiology","authors":["Mojoli, Francesco","Mongodi, Silvia","Grugnetti, Giuseppina","Muzzi, Alba","Baldanti, Fausto","Bruno, Raffaele","Triarico, Antonio","Antonio Iotti, Giorgio"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32235155","week":"202014|Mar 30 - Apr 05","doi":"10.1097/ALN.0000000000003325","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352135672135681,"score":55.155426},{"pmid":32267979,"title":"COVID-19: The Uninvited Guest in the Intensive Care Unit (ICU) Implications for Pharmacotherapy.","text":["COVID-19: The Uninvited Guest in the Intensive Care Unit (ICU) Implications for Pharmacotherapy.","As the number of cases of COVID-19 (SARS-CoV-2) rise in the United States (US), the number of severe cases (those requiring ICU admission) rise with it. Initially, the estimate for severe cases was approximated at 5% based on experience from China.(1, 2) However, the World Health Organization's (WHO) estimate from China for severe and critical cases is near 20% (Table).(3) The primary clinical feature of COVID-19 is pneumonia, the severity of which directs the clinical course; it has been estimated that, of patients admitted to the ICU, up to half may require either invasive or non-invasive ventilatory support.(4) This has created an unprecedented situation for emergency and critical care medicine.","Pharmacotherapy","Stringer, Kathleen A","Puskarich, Michael A","Kenes, Michael T","Dickson, Robert P","32267979"],"abstract":["As the number of cases of COVID-19 (SARS-CoV-2) rise in the United States (US), the number of severe cases (those requiring ICU admission) rise with it. Initially, the estimate for severe cases was approximated at 5% based on experience from China.(1, 2) However, the World Health Organization's (WHO) estimate from China for severe and critical cases is near 20% (Table).(3) The primary clinical feature of COVID-19 is pneumonia, the severity of which directs the clinical course; it has been estimated that, of patients admitted to the ICU, up to half may require either invasive or non-invasive ventilatory support.(4) This has created an unprecedented situation for emergency and critical care medicine."],"journal":"Pharmacotherapy","authors":["Stringer, Kathleen A","Puskarich, Michael A","Kenes, Michael T","Dickson, Robert P"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267979","week":"202015|Apr 06 - Apr 12","doi":"10.1002/phar.2394","keywords":["COVID-19","Corona virus","Intensive Care Unit","acute respiratory distress syndrome (ARDS)"],"source":"PubMed","locations":["US","United States","China"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1663609715744047104,"score":53.14668},{"pmid":32278367,"title":"COVID-19: Respiratory support outside the intensive care unit.","text":["COVID-19: Respiratory support outside the intensive care unit.","Lancet Respir Med","McEnery, Tom","Gough, Ciara","Costello, Richard W","32278367"],"journal":"Lancet Respir Med","authors":["McEnery, Tom","Gough, Ciara","Costello, Richard W"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32278367","week":"202016|Apr 13 - Apr 19","doi":"10.1016/S2213-2600(20)30176-4","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663890921974923264,"score":52.891495}]}